Watson Biotech: Planning to issue A-shares to specific targets; change of controller

Watson Bio announces that the company is planning to issue A-shares to specific investors, which may lead to a change in control. The company’s stock will be suspended from trading starting March 17, 2026 (Tuesday), with an expected suspension period of no more than two trading days.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin